← Back to Search

Patients with Barrett's Esophagus for Barrett's Esophagus

N/A
Recruiting
Led By Sachin Wani, MD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Patients with Barrett's related neoplasia and dysplasia. Patients with esophageal cancer
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Summary

A prospective outcomes study in patients with and esophageal cancer (EAC) and Barrett's esophagus (BE) associated neoplasia being evaluated for endoscopic eradication therapy (EET).

Eligible Conditions
  • Barrett's Esophagus
  • Esophageal Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Overall improvement of patient outcomes in patients treated with endoscopic eradication therapy (EET).
Secondary study objectives
Adverse event rates associated with EET for BE associated neoplasia and EAC.
Neoplasms
Impact of endoscopic and radiologic imaging modalities.
+11 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Patients with invasive esophageal cancerExperimental Treatment3 Interventions
Patients with invasive esophageal cancer who will be treated with surgery (esophagectomy), chemotherapy, radiation, and palliative treatment modalities.
Group II: Patients with Barrett's EsophagusExperimental Treatment1 Intervention
Patients with non-dysplastic Barrett's esophagus, patients with Barrett's related dysplasia which includes low-grade dysplasia, high-grade dysplasia and intramucosal cancer who will be evaluated and treated with endoscopic eradication therapies (EET).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Esophagectomy
2016
Completed Phase 3
~4130
Radiation
2003
Completed Phase 2
~780
Chemotherapy
2003
Completed Phase 4
~3050

Find a Location

Who is running the clinical trial?

Feinberg School of Medicine, Northwestern UniversityOTHER
33 Previous Clinical Trials
7,244 Total Patients Enrolled
University of Colorado, DenverLead Sponsor
1,786 Previous Clinical Trials
2,782,608 Total Patients Enrolled
Northwestern University Feinberg School of MedicineOTHER
40 Previous Clinical Trials
10,393 Total Patients Enrolled
~937 spots leftby Jan 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top